Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis
Among biologics used for treating psoriasis, there do not appear to be...
Psoriasis – February 2021 Edition
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
The first interchangeable biosimilar product to Humira (adalimumab) wa...
Smartphone App for Patients With Psoriasis Proves Beneficial
“eHealth devices are becoming increasingly popular among dermatologi...
PW PODCAST: The Evolution of CME
During a recent PW Podcast, Rachel Giles, MD, from Medicom Medical Pub...
A Tribute to the Pharmacist
This article originally appeared on KevinMD.com and is written by Tais...
